Will LDN therapy improve the quality of life of patients with fibromyalgia? (in Polish) (News)

05 May 2023
Medexpress.pl
https://www.medexpress.pl/blogosfera/czy-terapia-ldn-poprawi-jakosc-zycia-pacjentow-z-fibromialgia/

Pain associated with fibromyalgia: Benefits from low-dose naltrexone (in Italian)

National Courier
22 May 2023
https://www.corrierenazionale.it/2023/05/22/dolore-associato-alla-fibromialgia-benefici-da-basse-dosi-di-naltrexone/?noamp=mobile

Low-Dose Naltrexone Could Treat Long COVID Symptoms

verywellhealth
07 June 2023
https://www.verywellhealth.com/low-dose-naltrexone-long-covid-treatment-7507283

A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia

Heliyon
19 April 2023
https://pubmed.ncbi.nlm.nih.gov/37206027/

Low-Dose Naltrexone in Rheumatological Diseases

Mediterr J Rheumatol
31 March 2023
https://pubmed.ncbi.nlm.nih.gov/37223594/

Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders.

Pilot Study of Low-Dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-Controlled, Crossover Clinical Trial

Clin Ther
10 April 2023
https://pubmed.ncbi.nlm.nih.gov/37045708/

Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis

Aust J Gen Pract
April 2023
https://www1.racgp.org.au/ajgp/2023/april/low-dose-naltrexone-in-the-treatment-of-fibromyalg

Method: A systematic literature search was conducted using the key words 'naltrexone', 'fibromyalgia', 'fibrositis', 'chronic pain' and 'neurogenic inflammation'.

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087